随机对照试验的纳入标准。 - Suppr | 超能文献

Eligibility criteria of randomized controlled trials.

作者信息

Costantino Giorgio, Ceriani Elisa, Rusconi Anna Maria, Montano Nicola

出版信息

JAMA. 2007 Jul 4;298(1):39; author reply 39-40. doi: 10.1001/jama.298.1.39-a.

DOI:10.1001/jama.298.1.39-a

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Eligibility criteria of randomized controlled trials.随机对照试验的纳入标准。

JAMA. 2007 Jul 4;298(1):39; author reply 39-40. doi: 10.1001/jama.298.1.39-a.

2

Publication of trials funded by the National Heart, Lung, and Blood Institute.由美国国立心肺血液研究所资助的试验的发表。

N Engl J Med. 2014 Feb 20;370(8):782. doi: 10.1056/NEJMc1315653.

3

Publication of trials funded by the National Heart, Lung, and Blood Institute.由美国国立心肺血液研究所资助的试验报告。

N Engl J Med. 2014 Feb 20;370(8):781-2. doi: 10.1056/NEJMc1315653.

4

Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review.发表于高影响力综合医学期刊的随机对照试验的纳入标准：一项系统抽样综述

JAMA. 2007 Mar 21;297(11):1233-40. doi: 10.1001/jama.297.11.1233.

5

When it comes to trials, do we get what we pay for?说到试验，我们花钱能得到相应的回报吗？

N Engl J Med. 2013 Nov 14;369(20):1962-3. doi: 10.1056/NEJMe1310554.

6

Presenting randomised trial reports.展示随机试验报告。

Lancet. 1998 Jan 3;351(9095):69. doi: 10.1016/S0140-6736(05)78049-1.

7

Reporting the clinical importance of randomized controlled trials.报告随机对照试验的临床重要性。

CMAJ. 2002 Mar 19;166(6):712; author reply 712.

8

Reporting the clinical importance of randomized controlled trials.报告随机对照试验的临床重要性。

CMAJ. 2002 Mar 19;166(6):711-2; author reply 712.

9

Randomized controlled trials in Archives of General Psychiatry (1959-1995): a prevalence study.《普通精神病学文献》（1959 - 1995年）中的随机对照试验：一项患病率研究。

Arch Gen Psychiatry. 1998 Aug;55(8):754-5. doi: 10.1001/archpsyc.55.8.754.

10

Comparison of registered and published primary outcomes in randomized controlled trials.随机对照试验中注册的主要结局与发表的主要结局的比较。

JAMA. 2009 Sep 2;302(9):977-84. doi: 10.1001/jama.2009.1242.

引用本文的文献

1

Let's Agree to Disagree on Operative versus Nonoperative (LADON) treatment for proximal humerus fractures: Study protocol for an international multicenter prospective cohort study.让我们就肱骨近端骨折的手术与非手术（LADON）治疗达成共识：一项国际多中心前瞻性队列研究的研究方案。

PLoS One. 2022 Feb 25;17(2):e0264477. doi: 10.1371/journal.pone.0264477. eCollection 2022.

2

Precision Dosing Priority Criteria: Drug, Disease, and Patient Population Variables.精准给药优先标准：药物、疾病及患者群体变量

Front Pharmacol. 2020 Apr 22;11:420. doi: 10.3389/fphar.2020.00420. eCollection 2020.

3

Representation of therapy-related myelodysplastic syndrome in clinical trials over the past 20 years.过去 20 年临床试验中治疗相关骨髓增生异常综合征的表现。

Blood Adv. 2019 Sep 24;3(18):2738-2747. doi: 10.1182/bloodadvances.2019000293.